Vaccinomics for the major blood feeding helminths of humans

Alex Loukas*, Soraya Gaze, Jason P. Mulvenna, Robin B. Gasser, Paul J. Brindley, Denise L. Doolan, Jeffrey M. Bethony, Malcolm K. Jones, Geoffrey N. Gobert, Patrick Driguez, Donald P. McManus, Peter J. Hotez

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

34 Citations (Scopus)


Approximately one billion people are infected with hookworms and/or blood flukes (schistosomes) in developing countries. These two parasites are responsible for more disability adjusted life years lost than most other neglected tropical diseases (NTDs), and together, are second only to malaria. Although anthelmintic drugs are effective and widely available, they do not protect against reinfection, resistant parasites are likely to emerge, and mass drug administration programs are unsustainable. Therefore, there is a pressing need for the development of vaccines against these parasites. In recent years, there have been major advances in our understanding of hookworms and schistosomes at the molecular level through the use of "omics" technologies. The secretomes of these parasites have been characterized using transcriptomics, genomics, proteomics, and newly developed gene manipulation and silencing techniques, and the proteins of interest are now the target of novel antigen discovery approaches, notably immunomics. This research has resulted in the discovery, development, and early stage clinical trials of subunit vaccines against hookworms and schistosomes.

Original languageEnglish
Pages (from-to)567-577
Number of pages11
JournalOMICS A Journal of Integrative Biology
Issue number9
Publication statusPublished - 01 Sep 2011
Externally publishedYes

ASJC Scopus subject areas

  • Biotechnology
  • Biochemistry
  • Genetics
  • Molecular Biology
  • Molecular Medicine

Fingerprint Dive into the research topics of 'Vaccinomics for the major blood feeding helminths of humans'. Together they form a unique fingerprint.

Cite this